We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+11.92%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$191M
AUM Growth
-$59.3M
(-24%)
Cap. Flow
-$76.2M
Cap. Flow
% of AUM
-39.78%
Top 10 Holdings %
Top 10 Hldgs %
5.8%
Holding
489
New
53
Increased
164
Reduced
226
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
D.R. Horton
DHI
|
+$888K |
| 2 |
Lennar Class A
LEN
|
+$880K |
| 3 |
Microchip Technology
MCHP
|
+$860K |
| 4 |
Ametek
AME
|
+$859K |
| 5 |
Home Depot
HD
|
+$853K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Steel Dynamics
STLD
|
+$1.62M |
| 2 |
Cheniere Energy
CQP
|
+$1.53M |
| 3 |
STOR
STORE Capital Corporation
STOR
|
+$1.44M |
| 4 |
NOA
North American Construction
NOA
|
+$1.43M |
| 5 |
STR
Sitio Royalties
STR
|
+$1.41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.88% |
| 2 | Financials | 12.6% |
| 3 | Technology | 10.15% |
| 4 | Materials | 9.55% |
| 5 | Real Estate | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Gilead Sciences
GILD
$167B
| $294K | 0.15% |
3,423
-651
| -16% | -$51.6K |
|
277
Amgen
AMGN
$212B
| $293K | 0.15% |
1,116
+115
| +11% | +$30.8K |
|
278
Immunocore
IMCR
$1.7B
| $293K | 0.15% |
5,131
-3,507
| -41% | -$197K |
|
279
Axsome Therapeutics
AXSM
$12.1B
| $293K | 0.15% |
3,795
-6,618
| -64% | -$396K |
|
280
PTC Therapeutics
PTCT
$6.25B
| $292K | 0.15% |
7,648
-1,529
| -17% | -$63.6K |
|
281
Invesco Senior Income Trust
VVR
$454M
| $292K | 0.15% |
76,161
-21,299
| -22% | -$81.1K |
|
282
Legend Biotech
LEGN
$3.68B
| $291K | 0.15% |
5,832
+481
| +9% | +$23.3K |
|
|
IMGN
283
DELISTED
Immunogen Inc
IMGN
| $290K | 0.15% |
58,521
+26,180
| +81% | +$142K |
|
|
EVF
284
Eaton Vance Senior Income Trust
EVF
$89.9M
| $290K | 0.15% |
55,036
-6,929
| -11% | -$37K |
|
285
Biogen
BIIB
$30.4B
| $290K | 0.15% |
1,047
-168
| -14% | -$47.4K |
|
|
NOA
286
North American Construction
NOA
$370M
| $290K | 0.15% |
21,685
-115,927
| -84% | -$1.43M |
|
287
Kiniksa Pharmaceuticals
KNSA
$6.11B
| $290K | 0.15% |
19,345
-9,062
| -32% | -$132K |
|
288
BioMarin Pharmaceuticals
BMRN
$12B
| $289K | 0.15% |
2,792
-502
| -15% | -$47.1K |
|
|
BTX
289
BlackRock Technology and Private Equity Term Trust
BTX
$919M
| $286K | 0.15% |
41,928
+9,450
| +29% | +$67.4K |
|
290
BlackRock Floating Rate Income Trust
BGT
$322M
| $285K | 0.15% |
26,015
-5,124
| -16% | -$56.8K |
|
291
Harmony Biosciences
HRMY
$2.07B
| $284K | 0.15% |
5,159
-137
| -3% | -$7.53K |
|
|
BPMC
292
DELISTED
Blueprint Medicines
BPMC
| $284K | 0.15% |
6,474
+1,309
| +25% | +$62.8K |
|
|
EFT
293
Eaton Vance Floating-Rate Income Trust
EFT
$284M
| $282K | 0.15% |
25,471
-3,092
| -11% | -$34.9K |
|
294
BlackRock Floating Rate Income Strategies Fund
FRA
$381M
| $281K | 0.15% |
24,938
-4,304
| -15% | -$49.3K |
|
295
Aurinia Pharmaceuticals
AUPH
$1.92B
| $280K | 0.15% |
64,786
+39,866
| +160% | +$231K |
|
|
SAGE
296
DELISTED
Sage Therapeutics
SAGE
| $279K | 0.15% |
7,320
-68
| -0.9% | -$2.6K |
|
297
Gladstone Capital
GLAD
$436M
| $279K | 0.15% |
14,500
-4,812
| -25% | -$92.4K |
|
298
Agios Pharmaceuticals
AGIO
$2.14B
| $274K | 0.14% |
9,753
-4,050
| -29% | -$114K |
|
299
Oaktree Specialty Lending
OCSL
$1.06B
| $268K | 0.14% |
13,013
-3,935
| -23% | -$79.2K |
|
300
Zai Lab
ZLAB
$2.1B
| $265K | 0.14% |
8,625
-1,187
| -12% | -$37.4K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
RC
Virtus ETF Advisers's Q4 2022 Portfolio in Review
As of Q4 2022, Virtus ETF Advisers held 489 positions worth $191M, down 24% from $251M the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.
Virtus ETF Advisers withdrew a net $76.2M in Q4 2022, closing 46 positions and reducing 226 holdings. Its most notable exit was iShares JPMorgan USD Emerging Markets Bond ETF, an estimated $877K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 19% a quarter earlier, followed by Financials and Technology.
Against the trend, Virtus ETF Advisers opened a new position in D.R. Horton worth $987K.
- Virtus ETF Advisers's largest Q4 2022 buy was D.R. Horton: 11,078 shares worth $987K.
- Virtus ETF Advisers added most to Qualcomm in Q4 2022, an estimated $271K increase.
- Virtus ETF Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $1.62M.
- Virtus ETF Advisers fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2022, selling an estimated $877K.
- Virtus ETF Advisers's ten largest holdings make up 5.8% of its $191M portfolio in Q4 2022.
- Virtus ETF Advisers opened 53 new positions and closed 46 in Q4 2022.
- Virtus ETF Advisers's portfolio value fell 24% quarter-over-quarter to $191M.
Based on Virtus ETF Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.